EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease

Zaid S Salameh, Edward J Jacobs, Rafael V Davalos

Annals of Biomedical Engineering · 2026-09 · 54 (9) · 2961-2975

DOI: 10.1007/s10439-026-04044-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Biomedical Engineering, online erschienen am 28.02.2026. Verfasst von Zaid S Salameh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Atherosclerosis, Coronary Vessels, Catheter Ablation, Plaque, Atherosclerotic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Georgia Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Atherosclerotic vascular disease remains a leading cause of morbidity and mortality worldwide. Current treatments such as angioplasty, stenting, and atherectomy are invasive and limited by restenosis, thrombosis, and incomplete long-term efficacy. Pulsed field ablation (PFA), a nonthermal electroporation-based modality, has demonstrated safety in other cardiovascular applications, but it has not been applied for the treatment of endoluminal vascular diseases. We investigated whether pulsed electric fields could be delivered within the coronary artery and if PFA could selectively ablate the cellular components of atherosclerotic plaques.

Methods

An endoluminal bipolar PFA probe was fabricated using a balloon catheter with flexible electrodes and evaluated in potato and ex vivo porcine hearts. The electrical conductivities of human atherosclerotic plaques were derived from previous impedance measurements for patient-specific multi-tissue and single-cell electroporation modeling. PFA was then evaluated for selective decellularization within an electrical conductivity-matched 3D fibrotic atherosclerosis tissue mimic using high concentrations of human macrophages and aggregated oxidized low-density lipoproteins, encapsulated within a collagen matrix.

Results

Endoluminal probe positioning and high-voltage pulsed electric field delivery feasibility was established within the porcine left coronary arteries, with susequent potato lesions experiments demonstrating maximum ablations (6.99 cm 2 ) and current (13 A) with equal treatment parameters. The multi-tissue model then indicated that endoluminal PFA can effectively cover > 95% of severe and thick plaques with irreversible electroporation, with single-cell modeling supporting the electroporation of foam cells within the plaque. The 3D atherosclerosis mimic validated the ability of PFA to completely ablate the foam cells with fibrotic tissue at > 1000 V/cm.

Conclusions

This study provides practical demonstration of PFA for the treatment of atherosclerotic vascular disease. By combining experimental validation with computational modeling, we establish proof-of-concept that endoluminal PFA can selectively ablate diseased cells while preserving extracellular architecture, laying the groundwork for future translational development of this therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCoronary VesselsCatheter AblationPlaque, AtheroscleroticAnimalsSwineHumansIrreversible Electroporation Therapy

Stichwörter der Autor:innen

AtherosclerosisCatheterIrreversible electroporationPulsed field ablationVascular disease

Autor:innen und Institutionen

  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology Emory University, Atlanta, Georgia, USA.
  • Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology Emory University, Atlanta, Georgia, USA. Rafael.Davalos@bme.gatech.edu.
  • , 313 Ferst Drive NE, Atlanta, GA, 30318, USA. Rafael.Davalos@bme.gatech.edu.

Förderung

  • Georgia Institute of Technology

Zitieren

APA

Salameh, Z. S., Jacobs, E. J., & Davalos, R. V. (2026). Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease. Annals of Biomedical Engineering, 54(9), 2961-2975. https://doi.org/10.1007/s10439-026-04044-6

Vancouver

Salameh ZS, Jacobs EJ, Davalos RV. Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease. Annals of Biomedical Engineering. 2026;54(9):2961-2975. doi:10.1007/s10439-026-04044-6

BibTeX
@article{Salameh2026,
  author = {Salameh, Zaid S and Jacobs, Edward J and Davalos, Rafael V},
  title = {Endoluminal Catheter Pulsed Field Ablation for the Treatment of Atherosclerotic Vascular Disease},
  journal = {Annals of Biomedical Engineering},
  year = {2026},
  volume = {54},
  number = {9},
  pages = {2961--2975},
  doi = {10.1007/s10439-026-04044-6}
}
Kostenlos starten →